MedPath

Caffeine

Generic Name
Caffeine
Brand Names
Anacin, Arthriten Inflammatory Pain, Ascomp, Bc Arthritis, Bc Original Formula, Cafcit, Diurex, Dvorah, Esgic, Exaprin, Excedrin, Excedrin Tension Headache, Fioricet, Fioricet With Codeine, Fiorinal, Goody's Extra Strength, Goody's Headache Relief Shot, Goody's PM, Midol Complete, Midol Cramps & Bodyaches, Migergot, Norgesic, Norgesic Forte, Orbivan, Orphengesic, Pamprin Max Formula, Peyona, Stanback Headache Powder Reformulated Jan 2011, Trezix, Trianal, Trianal C, Triatec, Triatec-8, Vanatol, Vanatol S, Vanquish, Vivarin, Peyona (previously Nymusa), Gencebok
Drug Type
Small Molecule
Chemical Formula
C8H10N4O2
CAS Number
58-08-2
Unique Ingredient Identifier
3G6A5W338E
Background

Caffeine is a drug of the methylxanthine class used for a variety of purposes, including certain respiratory conditions of the premature newborn, pain relief, and to combat drowsiness. Caffeine is similar in chemical structure to Theophylline and Theobromine. It can be sourced from coffee beans, but also occurs naturally in various teas and cacao beans, which are different than coffee beans. Caffeine is also used in a variety of cosmetic products and can be administered topically, orally, by inhalation, or by injection.

The caffeine citrate injection, used for apnea of the premature newborn, was initially approved by the FDA in 1999. According to an article from 2017, more than 15 million babies are born prematurely worldwide. This correlates to about 1 in 10 births. Premature birth can lead to apnea and bronchopulmonary dysplasia, a condition that interferes with lung development and may eventually cause asthma or early onset emphysema in those born prematurely. Caffeine is beneficial in preventing and treating apnea and bronchopulmonary dysplasia in newborns, improving the quality of life of premature infants.

Indication

Caffeine is indicated for the short term treatment of apnea of prematurity in infants and off label for the prevention and treatment of bronchopulmonary dysplasia caused by premature birth. In addition, it is indicated in combination with sodium benzoate to treat respiratory depression resulting from an overdose with CNS depressant drugs. Caffeine has a broad range of over the counter uses, and is found in energy supplements, athletic enhancement products, pain relief products, as well as cosmetic products.

Associated Conditions
Acute Pain, Chronic Lung Disease of Prematurity, Common Cold, Dyspepsia, Fatigue, Fever, Flu caused by Influenza, Headache, Menstrual Pain, Myalgia, Pain, Pain caused by Rheumatism, Primary apnea of premature newborns, Respiratory Depression, Somnolence, Tension Headache, Toothache, Under-eyes Dark Circles, Vascular Headaches, Moderate Pain
Associated Therapies
Analgesia, Antacid therapy, Athletic Performance

The Effect of Tablet Size on Cognitive Performance Caffeine

Phase 4
Completed
Conditions
Placebo Effect
Interventions
Other: Placebo - small sucrose pill
Other: Placebo - large sucrose pill
First Posted Date
2018-10-03
Last Posted Date
2019-04-17
Lead Sponsor
University of Colorado, Denver
Target Recruit Count
120
Registration Number
NCT03694886
Locations
πŸ‡ΊπŸ‡Έ

University of Colorado Denver, Denver, Colorado, United States

Caffeine and Neurologic Recovery Following Surgery and General Anesthesia

Early Phase 1
Completed
Conditions
Pain, Postoperative
Interventions
Drug: Dextrose Water
First Posted Date
2018-07-05
Last Posted Date
2021-10-06
Lead Sponsor
University of Michigan
Target Recruit Count
71
Registration Number
NCT03577730
Locations
πŸ‡ΊπŸ‡Έ

Michigan Medicine, Ann Arbor, Michigan, United States

Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4

First Posted Date
2018-06-14
Last Posted Date
2025-02-24
Lead Sponsor
LEO Pharma
Target Recruit Count
40
Registration Number
NCT03556592
Locations
πŸ‡³πŸ‡±

LEO Pharma Investigational Site, Leiden, Netherlands

Drug-Drug Interaction (DDI) Study for TD-9855

Phase 1
Completed
Conditions
Drug Drug Interaction (DDI)
Interventions
First Posted Date
2018-02-14
Last Posted Date
2021-01-14
Lead Sponsor
Theravance Biopharma
Target Recruit Count
41
Registration Number
NCT03432793
Locations
πŸ‡ΊπŸ‡Έ

Celerion, Lincoln, Nebraska, United States

The Acute Effects of Caffeine on Exercise and Cognition

Phase 4
Completed
Conditions
Adult Population
Interventions
Behavioral: Moderate Intensity Exercise
First Posted Date
2018-01-17
Last Posted Date
2024-03-04
Lead Sponsor
Western University, Canada
Target Recruit Count
64
Registration Number
NCT03400423
Locations
πŸ‡¨πŸ‡¦

Western University, London, Ontario, Canada

A Study to Determine if Caffeine Accelerates Emergence From Propofol Anesthesia

Phase 4
Completed
Conditions
Anesthesia
Interventions
Drug: Placebo
First Posted Date
2017-12-04
Last Posted Date
2019-11-18
Lead Sponsor
University of Chicago
Target Recruit Count
8
Registration Number
NCT03360903
Locations
πŸ‡ΊπŸ‡Έ

The University of Chicago, Chicago, Illinois, United States

A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis

First Posted Date
2017-12-02
Last Posted Date
2025-04-25
Lead Sponsor
Janssen Research & Development, LLC
Target Recruit Count
28
Registration Number
NCT03358706
Locations
πŸ‡§πŸ‡ͺ

Ghent University Hospital, Gent, Belgium

πŸ‡§πŸ‡ͺ

Az Sint-Maarten, Mechelen, Belgium

πŸ‡¬πŸ‡§

Royal Liverpool University Hospital, Liverpool, United Kingdom

and more 13 locations

Moderately Preterm Infants With Caffeine at Home for Apnea (MoCHA) Trial

Phase 3
Terminated
Conditions
Apnea of Prematurity
Interventions
First Posted Date
2017-11-13
Last Posted Date
2024-07-31
Lead Sponsor
NICHD Neonatal Research Network
Target Recruit Count
827
Registration Number
NCT03340727
Locations
πŸ‡ΊπŸ‡Έ

Stanford University, Palo Alto, California, United States

πŸ‡ΊπŸ‡Έ

University of Alabama at Birmingham, Birmingham, Alabama, United States

πŸ‡ΊπŸ‡Έ

Duke University, Durham, North Carolina, United States

and more 13 locations

Intermittent Hypoxia and Caffeine in Infants Born Preterm

Phase 2
Completed
Conditions
Intermittent Hypoxia
Interventions
Drug: Placebos
First Posted Date
2017-10-26
Last Posted Date
2023-09-01
Lead Sponsor
Children's National Research Institute
Target Recruit Count
170
Registration Number
NCT03321734
Locations
πŸ‡ΊπŸ‡Έ

Children's National Medical Center/Children's Research Institute, Washington, District of Columbia, United States

πŸ‡ΊπŸ‡Έ

Loma Linda University Health System, Loma Linda, California, United States

πŸ‡ΊπŸ‡Έ

University of Massachusetss, Worcester, Massachusetts, United States

and more 12 locations

Caffeine for Preterm Infants With Apnea of Prematurity(AOP)

Not Applicable
Conditions
Apnea of Prematurity
Caffeine
Interventions
First Posted Date
2017-10-02
Last Posted Date
2017-10-02
Lead Sponsor
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Target Recruit Count
100
Registration Number
NCT03298347
Locations
πŸ‡¨πŸ‡³

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, Chongqing, Chongqing, China

Β© Copyright 2025. All Rights Reserved by MedPath